Cite
The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
MLA
Jiang, Hua, et al. “The Monoclonal Antibody CH12 Augments 5-Fluorouracil-Induced Growth Suppression of Hepatocellular Carcinoma Xenografts Expressing Epidermal Growth Factor Receptor Variant III.” Cancer Letters, vol. 342, no. 1, Jan. 2014, pp. 113–20. EBSCOhost, https://doi.org/10.1016/j.canlet.2013.08.038.
APA
Jiang, H., Dong, Q., Luo, X., Shi, B., Wang, H., Gao, H., Kong, J., Zhang, J., & Li, Z. (2014). The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Cancer Letters, 342(1), 113–120. https://doi.org/10.1016/j.canlet.2013.08.038
Chicago
Jiang, Hua, Qiongna Dong, Xiaoying Luo, Bizhi Shi, Huamao Wang, Huiping Gao, Juan Kong, Jiqin Zhang, and Zonghai Li. 2014. “The Monoclonal Antibody CH12 Augments 5-Fluorouracil-Induced Growth Suppression of Hepatocellular Carcinoma Xenografts Expressing Epidermal Growth Factor Receptor Variant III.” Cancer Letters 342 (1): 113–20. doi:10.1016/j.canlet.2013.08.038.